Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated-accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck

Thomas Kuhnt(Leipzig University), Juergen Dunst(Martin Luther University Halle-Wittenberg), Gerhard G. Grabenbauer(Klinikum Coburg), A. Pirnasch(University of Rostock), Thomas Wendt(Universität Trier), Andreas Schreiber(University of South Australia), Alexandra Sandner(Martin Luther University Halle-Wittenberg), Guido Lammering(Federal Highway and Transport Research Institute), Rita Engenhart‐Cabillic(Philipps University of Marburg), Michael Flentje(Universitätsklinikum Würzburg)
Annals of Oncology
April 29, 2010
10.1093/annonc/mdq216
Cited by 24

Related Papers

The RNA Binding Protein Quaking Regulates Formation of circRNAs
|Cell|2015|2.4k
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2015|723
Nomograms for Predicting Local Recurrence, Distant Metastases, and Overall Survival for Patients With Locally Advanced Rectal Cancer on the Basis of European Randomized Clinical Trials
|Journal of Clinical Oncology|2011|609
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
|Journal of Clinical Oncology|2019|550
Phase I/IIa Study of Cilengitide and Temozolomide With Concomitant Radiotherapy Followed by Cilengitide and Temozolomide Maintenance Therapy in Patients With Newly Diagnosed Glioblastoma
|Journal of Clinical Oncology|2010|445